Barclays Maintains Overweight on IFF, PT Down to $78 from $84
PorAinvest
viernes, 8 de agosto de 2025, 9:38 am ET1 min de lectura
BCS--
IFF has been making strategic acquisitions to expand its product offerings and market reach. On July 1, 2025, the company announced the acquisition of Dave Barry Plastics, a move aimed at enhancing its presence in the life sciences sector [2]. Additionally, IFF acquired Termomeccanica Industrial Compressors S.p.A. for approximately €160 million, further bolstering its industrial portfolio [3].
Despite these strategic moves, IFF's second-quarter 2025 earnings saw a drop in adjusted earnings but an increase in revenue. The company reported adjusted earnings per share (EPS) of $0.80, matching FactSet estimates, while revenue rose to $1.89 billion, exceeding the $1.85 billion forecast [4]. IFF has also revised its full-year 2025 revenue guidance upward, reflecting robust industrial demand [5].
Barclays' price target adjustment comes as other financial institutions have also recently revised their targets for IFF. Citigroup lowered its target to $94 from $104, while Goldman Sachs raised its target to $108 from $101 [6, 7]. These adjustments highlight the varied opinions among analysts regarding IFF's stock valuation.
IFF's stock has been subject to various price target adjustments by different financial institutions, with analysts expressing mixed ratings. UBS Group, Oppenheimer, Robert W. Baird, Mizuho, Morgan Stanley, and Barclays have all issued recent reports, with varying price targets and ratings [8].
Investors should note that IFF's stock has seen significant fluctuations in recent months. The stock traded down $5.02 on Wednesday, hitting $65.60, following UBS Group's target price reduction [8]. Despite the recent price drop, IFF has a 12-month low of $63.71 and a 12-month high of $106.77, indicating a wide range of price movements [8].
IFF's insiders have also been active in the stock market. EVP Stephen N. Landsman acquired 12,000 shares of the stock in May, while Director Kevin O'byrne bought 4,500 shares [9]. These insider purchases suggest confidence in the company's long-term prospects.
In conclusion, Barclays' adjustment of its price target on IFF reflects the mixed opinions among analysts regarding the stock's valuation. The recent acquisitions and earnings reports highlight IFF's strategic moves and market position. Investors should carefully consider the varied opinions and recent developments when evaluating IFF's stock.
References:
[1] https://www.marketscreener.com/news/barclays-adjusts-price-target-on-international-flavors-fragrances-to-78-from-84-maintains-overw-ce7c5edfdf8df12d
[2] https://www.marketscreener.com/news/ingersoll-rand-acquires-dave-barry-plastics-09-13am-mt-07-01-2025
[3] https://www.marketscreener.com/news/ingersoll-rand-acquires-termomeccanica-industrial-compressors-07-02-2025
[4] https://www.marketscreener.com/news/earnings-flash-ir-ingersoll-rand-inc-reports-q2-revenue-1-89b-vs-factset-est-of-1-85b-07-31-2025
[5] https://www.marketscreener.com/news/ingersoll-rand-revises-revenue-guidance-for-the-full-year-2025-07-31-2025
[6] https://www.marketscreener.com/news/citigroup-adjusts-price-target-on-ingersoll-rand-to-94-from-104-maintains-buy-rating-06-43am-mt-07-01-2025
[7] https://www.marketscreener.com/news/goldman-sachs-adjusts-price-target-on-ingersoll-rand-to-104-from-108-maintains-buy-rating-06-43am-mt-07-01-2025
[8] https://www.marketbeat.com/instant-alerts/international-flavors-fragrances-nyseiff-price-target-cut-to-7900-by-analysts-at-ubs-group-2025-08-06/
[9] https://www.marketscreener.com/news/insider-trading-activity-at-international-flavors-fragrances-07-31-2025
C--
DAVE--
FDS--
FISI--
Barclays Maintains Overweight on IFF, PT Down to $78 from $84
Barclays has adjusted its price target on International Flavors & Fragrances (IFF), lowering it from $84 to $78 while maintaining an "overweight" rating on the stock. The change comes amidst a series of recent developments, including IFF's acquisitions and earnings reports.IFF has been making strategic acquisitions to expand its product offerings and market reach. On July 1, 2025, the company announced the acquisition of Dave Barry Plastics, a move aimed at enhancing its presence in the life sciences sector [2]. Additionally, IFF acquired Termomeccanica Industrial Compressors S.p.A. for approximately €160 million, further bolstering its industrial portfolio [3].
Despite these strategic moves, IFF's second-quarter 2025 earnings saw a drop in adjusted earnings but an increase in revenue. The company reported adjusted earnings per share (EPS) of $0.80, matching FactSet estimates, while revenue rose to $1.89 billion, exceeding the $1.85 billion forecast [4]. IFF has also revised its full-year 2025 revenue guidance upward, reflecting robust industrial demand [5].
Barclays' price target adjustment comes as other financial institutions have also recently revised their targets for IFF. Citigroup lowered its target to $94 from $104, while Goldman Sachs raised its target to $108 from $101 [6, 7]. These adjustments highlight the varied opinions among analysts regarding IFF's stock valuation.
IFF's stock has been subject to various price target adjustments by different financial institutions, with analysts expressing mixed ratings. UBS Group, Oppenheimer, Robert W. Baird, Mizuho, Morgan Stanley, and Barclays have all issued recent reports, with varying price targets and ratings [8].
Investors should note that IFF's stock has seen significant fluctuations in recent months. The stock traded down $5.02 on Wednesday, hitting $65.60, following UBS Group's target price reduction [8]. Despite the recent price drop, IFF has a 12-month low of $63.71 and a 12-month high of $106.77, indicating a wide range of price movements [8].
IFF's insiders have also been active in the stock market. EVP Stephen N. Landsman acquired 12,000 shares of the stock in May, while Director Kevin O'byrne bought 4,500 shares [9]. These insider purchases suggest confidence in the company's long-term prospects.
In conclusion, Barclays' adjustment of its price target on IFF reflects the mixed opinions among analysts regarding the stock's valuation. The recent acquisitions and earnings reports highlight IFF's strategic moves and market position. Investors should carefully consider the varied opinions and recent developments when evaluating IFF's stock.
References:
[1] https://www.marketscreener.com/news/barclays-adjusts-price-target-on-international-flavors-fragrances-to-78-from-84-maintains-overw-ce7c5edfdf8df12d
[2] https://www.marketscreener.com/news/ingersoll-rand-acquires-dave-barry-plastics-09-13am-mt-07-01-2025
[3] https://www.marketscreener.com/news/ingersoll-rand-acquires-termomeccanica-industrial-compressors-07-02-2025
[4] https://www.marketscreener.com/news/earnings-flash-ir-ingersoll-rand-inc-reports-q2-revenue-1-89b-vs-factset-est-of-1-85b-07-31-2025
[5] https://www.marketscreener.com/news/ingersoll-rand-revises-revenue-guidance-for-the-full-year-2025-07-31-2025
[6] https://www.marketscreener.com/news/citigroup-adjusts-price-target-on-ingersoll-rand-to-94-from-104-maintains-buy-rating-06-43am-mt-07-01-2025
[7] https://www.marketscreener.com/news/goldman-sachs-adjusts-price-target-on-ingersoll-rand-to-104-from-108-maintains-buy-rating-06-43am-mt-07-01-2025
[8] https://www.marketbeat.com/instant-alerts/international-flavors-fragrances-nyseiff-price-target-cut-to-7900-by-analysts-at-ubs-group-2025-08-06/
[9] https://www.marketscreener.com/news/insider-trading-activity-at-international-flavors-fragrances-07-31-2025

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios